Medpace Holdings, Inc. (NASDAQ:MEDP) Short Interest Update

Medpace Holdings, Inc. (NASDAQ:MEDP) was the target of a large increase in short interest in the month of February. As of February 28th, there was short interest totalling 1,460,000 shares, an increase of 16.8% from the February 13th total of 1,250,000 shares. Based on an average daily volume of 292,800 shares, the short-interest ratio is currently 5.0 days. Currently, 5.8% of the shares of the company are short sold.

Institutional Inflows and Outflows

Large investors have recently modified their holdings of the company. R Squared Ltd purchased a new position in shares of Medpace during the 4th quarter valued at $30,000. SBI Securities Co. Ltd. purchased a new stake in Medpace in the 4th quarter worth $31,000. Stone House Investment Management LLC purchased a new stake in Medpace in the 3rd quarter worth $33,000. Jones Financial Companies Lllp lifted its stake in Medpace by 2,750.0% in the 4th quarter. Jones Financial Companies Lllp now owns 114 shares of the company’s stock worth $38,000 after purchasing an additional 110 shares in the last quarter. Finally, Lindbrook Capital LLC lifted its stake in Medpace by 27.6% in the 4th quarter. Lindbrook Capital LLC now owns 134 shares of the company’s stock worth $45,000 after purchasing an additional 29 shares in the last quarter. Hedge funds and other institutional investors own 77.98% of the company’s stock.

Analysts Set New Price Targets

Separately, Robert W. Baird boosted their price objective on shares of Medpace from $354.00 to $362.00 and gave the company a “neutral” rating in a research report on Monday, January 27th. Seven equities research analysts have rated the stock with a hold rating and five have assigned a buy rating to the company’s stock. According to MarketBeat, the company currently has an average rating of “Hold” and a consensus price target of $381.44.

Medpace Trading Up 1.4 %

Shares of MEDP traded up $4.54 during trading hours on Wednesday, reaching $327.47. 238,261 shares of the stock traded hands, compared to its average volume of 287,539. Medpace has a 52-week low of $302.01 and a 52-week high of $459.77. The company’s 50-day moving average price is $339.49 and its two-hundred day moving average price is $340.34. The company has a market cap of $9.98 billion, a P/E ratio of 25.93, a price-to-earnings-growth ratio of 3.81 and a beta of 1.47.

Medpace (NASDAQ:MEDP) last released its earnings results on Monday, February 10th. The company reported $3.67 earnings per share for the quarter, beating analysts’ consensus estimates of $2.96 by $0.71. Medpace had a net margin of 19.17% and a return on equity of 51.48%. On average, research analysts forecast that Medpace will post 12.29 EPS for the current year.

Medpace Company Profile

Medpace Holdings, Inc engages in the provision of outsourced clinical development services to the biotechnology, pharmaceutical and medical device industries. Its services include medical department, clinical trial management, data-driven feasibility, study-start-up, clinical monitoring, regulatory affairs, patient recruitment and retention, medical writing, biometrics and data sciences, pharmacovigilance, core laboratory, laboratories, clinics, and quality assurance.